Cargando…

A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma

The cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regimen, containing doxorubicin (DXR), which is a key drug for aggressive non-Hodgkin lymphoma (NHL), is a standard chemotherapeutic regimen; however, its administration in elderly patients is often intolerable. Pirarubicin (tet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohmachi, Ken, Ogura, Michinori, Kagami, Yoshitoyo, Imai, Yosuke, Hirose, Takayuki, Kinoshita, Tomohiro, Nagai, Hirokazu, Ohnishi, Kazunori, Hotta, Tomomitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JSLRT 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898716/ https://www.ncbi.nlm.nih.gov/pubmed/36575000 http://dx.doi.org/10.3960/jslrt.22026

Ejemplares similares

A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma
por: Ohnishi, Kazunori, et al.
Publicado: (2021)

Novel Interleukin‐2 Dependent T‐Cell Line Derived from Adult T‐Cell Leukemia Not Associated with Human T‐Cell Leukemia Virus Type I
por: Kagami, Yoshitoyo, et al.
Publicado: (1993)

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A
por: Kinoshita, Tomohiro, et al.
Publicado: (2021)

A SOLUBLE‐FACTOR(S) SECRETED BY A HUMAN SKIN CANCER CELL LINE SUPPORTS CLONAL GROWTH OF ADULT T‐CELL LEUKEMIA CELLS
por: Kagami, Yoshitoyo, et al.
Publicado: (1988)

R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
por: Ogura, Michinori, et al.
Publicado: (2018)

Good cop, bad cop: challenging patients to make hard decisions about aggressive treatment
por: Richards, Katrina
Publicado: (2011)

Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial
por: Kobayashi, Tsutomu, et al.
Publicado: (2022)

Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406
por: Ogura, Michinori, et al.
Publicado: (2023)

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
por: Kagami, Yoshitoyo, et al.
Publicado: (2020)

P1520: PROGNOSTIC IMPACT OF FEBRILE NEUTROPENIA AND DOSE INTENSITY OF R-CHOP THERAPY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA, A SUPPLEMENTARY ANALYSIS OF JCOG0601
por: Yoshida, Isao, et al.
Publicado: (2023)

Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma
por: Nakamura, Shigeo, et al.
Publicado: (1994)

Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
por: Nagai, Shin, et al.
Publicado: (2018)

GPR40: Good Cop, Bad Cop?
por: Alquier, Thierry, et al.
Publicado: (2009)

E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma: A phase I study
por: Ohmachi, Ken, et al.
Publicado: (2018)

Prognostic Impact of a Body Mass Index Decrease during First Chemotherapy in Patients with Advanced Follicular Lymphoma
por: Ito, Makoto, et al.
Publicado: (2022)

Good Cop, Bad Cop: The Different Roles of SRPKs
por: Nikolakaki, Eleni, et al.
Publicado: (2022)

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study
por: Ohmachi, Ken, et al.
Publicado: (2018)

T‐Cell Phenotype Is Associated with Decreased Survival in Non‐Hodgkin's Lymphoma
por: Shimizu, Kazuyuki, et al.
Publicado: (1989)

Piceatannol and Its Metabolite, Isorhapontigenin, Induce SIRT1 Expression in THP-1 Human Monocytic Cell Line
por: Kawakami, Shinpei, et al.
Publicado: (2014)

Establishment of an ATLL cell line (YG-PLL) dependent on IL-2 and IL-4, which are replaced by OX40-ligand(+) HK with poly-L-histidine and dermatan sulfate
por: Kagami, Yoshitoyo, et al.
Publicado: (2021)

Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma
por: Sharma, Niyati Seshagiri, et al.
Publicado: (2023)

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
por: Ogura, Michinori, et al.
Publicado: (2013)

Copping Out on Food Systems: How COP26 Failed to Address Food and Climate and How COP27 Can Solve It
por: Clément, Chantal Wei-Ying
Publicado: (2022)

Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome‐wide cDNA Microarray Analysis
por: Kaneta, Yasuyuki, et al.
Publicado: (2002)

PS, cops and copper
Publicado: (1969)

zeta-COP, a subunit of coatomer, is required for COP-coated vesicle assembly
Publicado: (1993)

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021)

3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis
por: Araie, Hiroaki, et al.
Publicado: (2017)

A New Type of COP: The Role of Circulating Osteoprogenitor (COP) Cells in Health and Disease
por: Duque, Gustavo
Publicado: (2021)

Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study
por: Izutsu, Koji, et al.
Publicado: (2021)

The game of cops and robbers on graphs
por: Bonato, Anthony, et al.
Publicado: (2011)

Traffic COPs: rules of detection
por: Spang, Anne
Publicado: (2013)

Telling the Truth for Fear of the “Cop”
por: Preston, S. H.
Publicado: (1891)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines
por: Klasse, Per Johan, et al.
Publicado: (2012)

Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad cop
por: Dietzold, Jillian, et al.
Publicado: (2015)

Copper Chaperone CupA and Zinc Control CopY Regulation of the Pneumococcal cop Operon
por: Neubert, Miranda J., et al.
Publicado: (2017)

Good Cop, Bad Cop: Defining the Roles of Δ40p53 in Cancer and Aging
por: Steffens Reinhardt, Luiza, et al.
Publicado: (2020)

The presence of β’1-COP and β’2-COP is required for female and male gametophyte development
por: Sánchez-Simarro, Judit, et al.
Publicado: (2023)

GHG Monitoring Project for the Global Stocktake 2023: implications of the COP26 Japan Pavilion seminar
por: Oda, Tomohiro
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ahmmrj74hv06sqd1te8ltj3fgk